Ocugen - OCGN
Total Followers: | 0 |
|
|
Follow |
Latest OCGN News
- Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock - GlobeNewswire Inc. - Fri, May 10, 2024 8:05 PM
- Ocugen to Present at May 2024 Investor Conferences - GlobeNewswire Inc. - Fri, May 10, 2024 11:45 AM
- Ocugen to Host Conference Call on Tuesday, May 14 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2024 Financial Results - GlobeNewswire Inc. - Fri, May 3, 2024 11:30 AM
- Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congress - GlobeNewswire Inc. - Thu, May 2, 2024 11:15 AM
- Can Ocugen Stock Keep Churning Higher? - The Motley Fool - Mon, Apr 29, 2024 12:30 PM
- Ocugen Announces OCU400—Modifier Gene Therapy—Phase 1/2 Data Presentation at Retinal Cell and Gene Therapy Innovation Summit 2024 - GlobeNewswire Inc. - Mon, Apr 29, 2024 10:45 AM
- Ocugen (OCGN) to Report Q1 Earnings: What's in the Cards? - Zacks Investment Research - Fri, Apr 26, 2024 4:35 PM
- UPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting - GlobeNewswire Inc. - Fri, Apr 26, 2024 1:05 PM
- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting - GlobeNewswire Inc. - Fri, Apr 26, 2024 10:30 AM
- Key Takeaways From Ocugen Analyst Ratings - Benzinga - Mon, Apr 22, 2024 12:01 PM
Link Copied to Clipboard!